Zhongnan Medical Journal Press

Home Results

A total of 86 result was found. Results that relate to safety

Meta-analysis of efficacy and safety of external treatment of acute soft tissue injury with traditional Chinese medicine

Published on Frontiers in Pharmaceutical Sciences 2026,30(1):128-137.
4283 times 976 times

ZHANG Zhiwei QU Ting LI Xiaoxing WANG Yong CHEN Donghui CHENG Yan

External treatment of traditional Chinese medicine Acute soft tissue injury Systematic evaluation Meta-analysis Safety Efficacy Visual analogue scale Randomized controlled trial
Details
Mepolizumab for refractory chronic rhinosinusitis with nasal polyps: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2026,35(2):192-199.
6578 times 1117 times

GU Shilong ZHANG Wenjing GUO Hao

Mepolizumab Refractory chronic rhinosinusitis with nasal polyps Effectiveness safety Cost-effectiveness
Details
Systematic review and Meta-analysis of traditional Chinese medicine in the treatment of mild cognitive impairment

Published on Frontiers in Pharmaceutical Sciences 2026,30(3):477-490.
7212 times 910 times

ZENG Baoqi TANG Chunbian DOU Lin SHENG Feng SUN Feng

Traditional Chinese medicine Cognitive function Mild cognitive impairment Activities of daily living Meta-analysis Randomized controlled trial Adverse reaction Safety
Details
Rapid health technology assessment of PARP inhibitors in the treatment of recurrent ovarian cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(4):439-450.
2912 times 678 times

LI Anna LI Jianping CHEN Wenjun ZUO Jing HUANG Xiaolu MENG Jun

Poly ADP ribose polymerase inhibitors Recurrent ovarian cancer Rapid health technology assessment Efficacy Safety Economy
Details
A survey on the knowledge, attitudes and practices regarding self-medication among parents of children in Xiamen and its influencing factors

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):526-534.
2840 times 715 times

WU Xiuquan LI Suping CHEN Yushuang YE Mengling HU Xiangguang

Self-medication Knowledge-attitude-practice Parents Medication safety
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (17): application of predictive models in drug effectiveness and safety evaluation

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):481-492.
2777 times 678 times

NIE Xiaolu WU Yunxiao ZHAO Houyu ZHAN Siyan SUN Feng

Predictive models Pharmacoepidemiology Precision Medicine Ef-fectiveness evaluation Safety evaluation Heterogeneity of treatment effects Biomarkers
Details
Research progress on the hepatoprotective effects and safety evaluation of sophocarpine

Published on Frontiers in Pharmaceutical Sciences 2026,30(4):692-698.
2183 times 547 times

JIANG Jingjing WANG Changlin SONG Chunhong LI Yanan

Sophocarpine Hepatoprotective effect Safety evaluation Lipid metabolism An-ti-fibrosis Anti-inflammatory Anti-tumor Hepatotoxicity Acute toxicity
Details
Survey on knowledge, attitudes, and practices among residents in the Ningxia and analysis of influencing factors

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):635-644.
1460 times 412 times

SUN Lixia ZHANG Xiaoli JI Hongyan

Knowledge-attitude-practice Medication risks Medication safety Influencing factors
Details
Real-world study of generic versus branded meropenem in the treatment of hospital-acquired pneumonia patients with traumatic brain injury

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):660-668.
1907 times 533 times

SHEN Jie TANG Lian CHEN Xianglong YANG Lijuan LI Tongtong MA Mian DENG Peng XU Jinhui

Meropenem Generic drug Branded drug Hospital-acquired pneumonia Traumatic brain injury Efficacy Safety Economy
Details
Rapid health technology assessment of donanemab in the treatment of Alzheimer's disease

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):800-809.
1105 times 339 times

FAN Liming DENG Tiantian LAN Haiyue DONG Yafen QIU Yan WANG Jian

Donanemab Alzheimer's disease Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Meta-analysis of efficacy and safety of pertuzumab biosimilars versus original drug in the treatment of patients with HER2-positive breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):810-817.
1053 times 333 times

GU Shilong ZHANG Wenjing GUO Hao

Pertuzumab Biosimilars Original drug HER2 Breast cancer Efficacy Safety Meta-analysis
Details